Preformed Line Products Co. (PLPC) Drops 10.35% on January 15

Equities Staff |

Preformed Line Products Co. (PLPC) was one of the Russell 2000's biggest losers for Friday January 15 as the stock slid 10.35% to $38.28, a loss of $-4.42 per share. Starting at an opening price of $41.77 a share, the stock traded between $38.28 and $41.77 over the course of the trading day. Volume was 1,237 shares over 22 trades, against an average daily volume of 6,522 shares and a total float of 5.27 million.

The losses send Preformed Line Products Co. down to a market cap of $201.81 million. In the last year, Preformed Line Products Co. has traded between $53.30 and $28.30, and its 50-day SMA is currently $41.85 and 200-day SMA is $38.72.

The stock has a P/E Ratio of 37.5.

Preformed Line Products Co designs, manufactures & sells hardware used inenergy & other utility networks, communication products & mounting hardware for solar power applications. It offers cable anchoring; control hardware & splice enclosures.

Preformed Line Products Co. is based out of Mayfield Village, OH and has some 2,744 employees. Its CEO is Robert G. Ruhlman.

For a complete fundamental analysis analysis of Preformed Line Products Co., check out’s Stock Valuation Analysis report for PLPC. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets


D-Wave Systems is the first quantum computing company. Its mission is to integrate new discoveries in physics, engineering, manufacturing, and computer science into breakthrough approaches to computation to help solve…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…